Petco reported stronger-than-expected first-quarter 2026 results, driven by a return to positive comparable sales growth and improved profitability. The company said early results validate its ongoing turnaround strategy and reaffirmed its full-year outlook.
A new Elanco survey found most pet owners plan to maintain or increase spending on pet health despite economic pressures, reinforcing the company’s long-term growth outlook for the animal health industry.
The Feline Veterinary Medical Association and EveryCat Health Foundation have named two veterinary students as recipients of their 2026 scholarships supporting careers in feline clinical practice and feline-focused research. The awards reflect ongoing efforts to strengthen the pipeline of veterinarians dedicated to feline health and wellbeing.
epiq Animal Health and Vetirus Animal Health have entered a distribution agreement aimed at accelerating adoption of platelet-rich plasma (PRP) therapies in companion animal and equine medicine, bringing broader access to regenerative treatment options for veterinarians across the United States.
Sign up for free to receive the latest veterinary news, product announcements, and industry developments.
Animal health veteran Kent Luther has been named vice president of sales and commercial operations at Pegasus Laboratories, bringing more than 30 years of industry leadership experience to the company.
The addition gives veterinary practices access to a complete anesthesia portfolio from a single supplier, including induction, maintenance and reversal products.
A new Spot Pet Insurance survey of more than 4,000 U.S. pet owners finds veterinary expenses increasingly shape financial decisions, career choices, and even relationships.
The U.S. pet industry continues to grow steadily, reaching $158 billion in 2025 with projections for further expansion in 2026, as generational shifts and value-driven spending reshape the market.
A new AAEP study shows wearable biometric sensors may help identify injury risk in racehorses earlier, supporting more proactive health management.
Bimeda has announced the upcoming U.S. launch of Gastrobim™ (omeprazole), the first FDA-approved bioequivalent to GastroGard®, expanding access to equine gastric ulcer treatment.
Parnell has launched nixiFLOR, an FDA-approved injectable solution combining florfenicol and flunixin meglumine for the treatment of bovine respiratory disease and control of fever in beef and non-lactating dairy cattle.
Agtech company Halter has raised $220 million in Series E funding at a $2 billion valuation to accelerate global expansion of its virtual fencing platform used by ranchers and livestock producers.
Jun 10–Jun 13, 2026 | Seattle
Jun 16–Jun 19, 2026 | Ho Chi Minh City
Jul 9–Jul 12, 2026 | Gulf Shores, AL
Jul 10–Jul 14, 2026 | Anaheim, CA
Aug 16–Aug 18, 2026 | Nashville, TN
